John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 8,358 shares at $205.45 ($1.7M) on 2025-11-07, disclosed to the SEC on 2025-11-12.
Seasonal sale ($1.7M) by Director — this insider has traded LGND in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $205.45 | 2,034 | $418K | 24.3% |
| 2 | $205.45 | 2,034 | $418K | 24.3% |
| 3 | $205.45 | 2,145 | $441K | 25.7% |
| 4 | $205.45 | 2,145 | $441K | 25.7% |
| Total | $205.45 avg | 8,358 | $1.7M | 100% |
| Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |
| IMNM | BUY | 2021-05-26 | $196K | — | Filing → |